// App-Quantinova.ai

596 : Effect of Tofacitinib on Patient-Reported Outcomes in Patients with Active Psoriatic Arthritis: Results from 2 Phase 3 Studies

Researchers

Presenter

  • Vibeke Strand

Principal Investigators

  • Kurt de Vlam

  • Jose A Covarrubias-Cobos

  • Philip J Mease

  • Dafna D Gladman

  • Thijs Hendrikx

  • Elizabeth Kudlacz

  • Daniela Graham

  • Joseph Wu

  • Joseph C Cappelleri

  • Ming-Ann Hsu

Medical Centers

  • Stanford Univ, Palo Alto, CA

  • KU Leuven, Leuven, Belgium

  • Unidad Reumatologica Las Americas S.C.P., Merida, Mexico

  • Swedish Medical Center and University of Washington School of Medicine, Seattle, WA

  • Department of Medical Imaging, University of Toronto, Toronto General Hospital, Toronto, ON, Canada

  • Pfizer Inc, Collegeville, PA

  • Pfizer, Groton, CT

Locations

  • United States

  • Belgium

  • Mexico

  • Canada

Companies

  • Pfizer Inc.

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Tasocitinib

  • Adalimumab

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

Phase

  • III

Study Id's

  • NCT01877668]

  • NCT01882439]

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved